msadmin
Medical, Healthcare, & Biotech/Pharma AI News
319
Altman-backed Merge Labs licenses Butterfly chips to link brains
Merge Labs licenses Butterfly Network's ultrasound chips to build brain-computer interfaces.
California sends Newsom a bill to ban AI chatbot therapy
California's legislature passes SB 903, banning AI bots from offering therapy.
China clears Mprosevir, its first AI-assisted Class 1 drug
NMPA clears Westlake's Mprosevir, China's first AI-assisted Class 1 drug.
Cureety absorbs Reimagine Care to watch cancer patients between visits
Cureety acquires Reimagine Care, pairing AI-driven triage with oncology clinical teams across 250 centers.
Heartvue’s cardiac MRI AI clears FDA with self-update built in
FDA clearance for Heartvue.Proton includes a PCCP that lets the cardiac MRI AI learn without refiling.
Ono taps Aitia’s causal AI twins to unmask neurology drug targets
Ono Pharma will use Aitia's causal AI digital twins to find new drug targets in neurological disease.
Superluminal scores $60M to carry AI-designed obesity pill to clinic
Superluminal Medicines banks $60M to take its AI-designed MC4R obesity drug into Phase 1.
Seattle’s big three institutes launch $95M AI BioDesign accelerator
Allen Institute, UW and Fred Hutch launch the $95M AI BioDesign accelerator to engineer biology with AI.